Mustang Non Operating Income Net Other from 2010 to 2024

MBIO Stock  USD 0.18  0.01  6.32%   
Mustang Bio Non Operating Income Net Other yearly trend continues to be very stable with very little volatility. Non Operating Income Net Other is likely to drop to about 638.4 K. During the period from 2010 to 2024, Mustang Bio Non Operating Income Net Other quarterly data regression pattern had range of 1.4 M and standard deviation of  484,214. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2010-12-31
Previous Quarter
814.2 K
Current Value
638.4 K
Quarterly Volatility
484.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
  
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.

Latest Mustang Bio's Non Operating Income Net Other Growth Pattern

Below is the plot of the Non Operating Income Net Other of Mustang Bio over the last few years. It is Mustang Bio's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mustang Bio's overall financial position and show how it may be relating to other accounts over time.
Non Operating Income Net Other10 Years Trend
Slightly volatile
   Non Operating Income Net Other   
       Timeline  

Mustang Non Operating Income Net Other Regression Statistics

Arithmetic Mean327,509
Coefficient Of Variation147.85
Mean Deviation439,142
Median505,000
Standard Deviation484,214
Sample Variance234.5B
Range1.4M
R-Value0.82
Mean Square Error81.5B
R-Squared0.68
Significance0.0002
Slope89,105
Total Sum of Squares3.3T

Mustang Non Operating Income Net Other History

2024638.4 K
2023814.2 K
2020708 K
20191.3 M
2018569 K
2017505 K

About Mustang Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Mustang Bio income statement, its balance sheet, and the statement of cash flows. Mustang Bio investors use historical funamental indicators, such as Mustang Bio's Non Operating Income Net Other, to determine how well the company is positioned to perform in the future. Although Mustang Bio investors may use each financial statement separately, they are all related. The changes in Mustang Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mustang Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mustang Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mustang Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Operating Income Net Other814.2 K638.4 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Mustang Stock

When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out the analysis of Mustang Bio Correlation against competitors.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.56)
Revenue Per Share
(0)
Return On Assets
(0.56)
Return On Equity
(3.22)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.